Cytoprotective Actions of FTY720 Modulate Severe Preservation Reperfusion Injury in RatRenal Transplants

Background. Fingolimod (FTY720) is a potent agonist of sphingosine 1 phosphate receptors and thereby interferes with lymphocyte trafficking. We previously showed that FIY720 protects from mild preservation reperfusion injury induced by 4 hr of cold ischemia. The purpose of this study was to explore the role of FTY720 in ischemic injury and regeneration using a clinically relevant rat renal transplant model with 24 hr of cold ischemia. Methods. Donor kidneys were cold stored in the University of Wisconsin solution for 24 hr before transplantation into bilaterally nephrectomized syngeneic recipients (n=6 per group), which received 0.5 mg/kg/d FTY720 or vehicle through oral gavage. Grafts were harvested 2 or 7 days posttransplantation. Renal tissue was examined histologically, stained for apoptosis, proliferation, inflammatory cell infiltrates, and studied for transforming growth factor-b, and tumor necrosis factor-a expression. Rat proximal tubular cells were incubated with 0.1 to 30 kmol/L of phosphorylated FTY720 to test for in vitro cytopathic effects. Results. FTY720 induced peripheral lymphopenia and significantly reduced intragraft CD3 super(+) and ED1 super(+) infiltrates. Acute tubular damage scores and graft function were not influenced by FTY720. Tubular apoptosis was significantly reduced, whereas the number of proliferating cell nuclear antigen-positive tubular cells were markedly increased. FTY720 attenuated renal tumor necrosis factor-a and transforming growth factor-b expression. In vitro, pharmacologic concentrations up to 1 kmol/L of phosphorylated FTY720 did not affect tubular cell viability. Conclusion. FTY720 confers tubular epithelial protection in the presence of severe preservation reperfusion injury. Beneficial effects may in part be due to reduction in cell-mediated immune mechanisms. Furthermore, FTY720 could be helpful in patients with delayed graft function.